Global Fractional Flow Reserve Market Report Analysed by Size, Share, Growth, Industry Demand and Forecast to 2024

Fractional Flow Reserve Market

The Fractional Flow Reserve Market growth is largely driven by the increasing geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost-benefits of FFR, and the presence of a favorable reimbursement scenario. Emerging economies are expected to present market players with a wide range of opportunities.

The Fractional Flow Reserve Market is projected to reach USD 1,082 million by 2024 from USD 516 million in 2019, at a CAGR of 16.0% during the forecast period.

Download PDF Brochure:

Fractional Flow Reserve Market
Fractional Flow Reserve Market

The invasive monitoring segment accounted for the largest share of the market in 2018

On the basis of technology, the market is segmented into invasive and non-invasive monitoring technologies. In 2018, the invasive monitoring segment accounted for the largest share of the Fractional Flow Reserve Market. The large share of this segment can be attributed to the strong recommendation for FFR usage in coronary angiography.

Recent Developments in Fractional Flow Reserve Market:

  • In 2017, Abbott acquired St. Jude Medical, Inc., one of the leading players in cardiovascular and neuromodulation products. 
     Abbott Laboratories is a healthcare company that develops, manufactures, and markets a broad and diverse range of health care products. The company operates through four business segments, namely, Established Pharmaceuticals, Diagnostic Products, Nutritional Products, and Cardiovascular and Neuromodulation Products. The company is present in Africa, Asia Pacific, Europe, Latin America, the Middle East, North America, and South America.
  • In 2017, HeartFlow, Inc. entered into an agreement with Royal Philips
     Founded in 2007 and headquartered in California (US), HeartFlow is a personalized medical technology company seeking to transform the way cardiovascular disease is diagnosed and treated. The company provides Heartflow FFR-CT, the first available non-invasive solution that enables a physician to more accurately evaluate whether a patient has significant coronary artery disease (CAD) based on both anatomy and physiology. HeartFlow FFRct leverages deep learning to create a personalized 3D model of the patient’s arteries. Through this agreement, Philips will promote the use of the HeartFlow FFRct Analysis in conjunction with Philips’ advanced catheters for the imaging and assessment of a patient’s coronary arteries.

Read a Press Release on “Fractional Flow Reserve Market”:

Key Questions addressed by the report:

  • Which are the key players in the market, and how intense is the competition?
  • Emerging countries present immense opportunities for the growth of Fractional Flow Reserve Market. Will this situation persist?
  • Which product markets will dominate in the future?
  • What are the challenges hindering the adoption of fractional flow reserve solutions?